adult
epic
studi
popul
previous
describ
brief
adult
year
old
hospit
cap
enrol
hospit
chicago
illinoi
hospit
nashvil
tennesse
three
hospit
academ
medic
center
publicli
fund
counti
hospit
commun
hospit
enrol
patient
clinic
sign
cap
includ
sign
acut
infect
fever
chill
hypothermia
leukocytosi
leukopenia
alter
mental
statu
sign
acut
respiratori
ill
cough
sputum
product
chest
pain
dyspnea
tachypnea
abnorm
lung
examin
respiratori
failur
enrol
also
requir
radiograph
evid
pneumonia
interpret
studyded
thorac
radiologist
blind
clinic
data
sera
collect
enrol
patient
store
studi
popul
current
analysi
includ
patient
enrol
adult
epic
studi
comprehens
pathogen
test
defin
suffici
bank
sera
measur
pct
pct
concentr
measur
research
laboratori
enrol
center
use
vida
brahm
pct
immunoassay
kit
marci
l
etoil
franc
lower
limit
pct
detect
ngml
studi
personnel
perform
pct
measur
blind
clinic
inform
treat
clinician
blind
pct
result
enrol
patient
underw
systemat
pathogen
test
per
studi
protocol
bacteri
test
includ
blood
cultur
sputum
cultur
limit
highqual
specimen
defin
epitheli
cell
white
blood
cell
per
lowpow
field
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophila
binaxnow
aler
revers
transcriptas
polymeras
chain
reaction
rtpcr
nasopharyngealoropharyng
npop
swab
chlamydophila
pneumonia
mycoplasma
pneumonia
sputum
legionella
bacteri
cultur
perform
highqual
endotrach
aspir
bronchoalveolar
lavag
sampl
obtain
routin
clinic
care
bacteri
cultur
rtpcr
enterobacteriacea
haemophilu
influenza
pseudomona
aeruginosa
staphylococcu
aureu
streptococcu
anginosu
streptococcu
miti
streptococcu
pneumonia
streptococcu
pyogen
also
complet
pleural
fluid
sampl
obtain
clinic
care
viral
test
includ
rtpcr
npop
swab
cdcdevelop
method
adenoviru
coronavirus
human
metapneumoviru
human
rhinoviru
influenza
virus
parainfluenza
virus
respiratori
syncyti
viru
acut
convalesc
week
later
serolog
test
adenoviru
human
metapneumoviru
influenza
virus
parainfluenza
virus
respiratori
syncyti
viru
pathogen
test
complet
routin
clinic
care
includ
mycobacteri
fungal
test
also
incorpor
etiolog
determin
patient
underw
least
bacteri
test
least
viral
test
describ
consid
adequ
pathogen
test
includ
final
studi
popul
classifi
patient
follow
pathogen
group
base
test
result
outlin
typic
bacteria
detect
bacteria
atyp
atyp
bacteria
pneumonia
c
pneumonia
legionella
viral
detect
viru
without
codetect
bacteria
mycobacterialfung
unknown
detect
pathogen
patient
codetect
pathogen
multipl
group
classifi
accord
follow
rule
codetect
typic
bacteria
atyp
andor
viru
classifi
typic
bacteria
codetect
atyp
bacteria
viru
classifi
atyp
compar
pct
distribut
patient
viral
group
atyp
typic
bacteri
group
wilcoxon
ranksum
test
use
pct
cutpoint
describ
literatur
threshold
identifi
bacteri
infect
guid
antibiot
therapi
categor
pct
valu
strata
ngml
ngml
ngml
ngml
preval
pathogen
group
within
pct
strata
calcul
calcul
stratifi
initi
locat
hospit
gener
medic
floor
intens
care
unit
icu
among
patient
typic
bacteri
detect
also
categor
patient
accord
type
test
posit
bacteria
blood
cultur
respiratori
sampl
urinari
antigen
test
compar
serum
pct
concentr
patient
posit
typic
bacteria
across
differ
categori
posit
test
evalu
accuraci
pct
identifi
bacteri
cap
separ
analys
first
compar
patient
bacteri
pathogen
includ
typic
atyp
bacteria
patient
viral
pathogen
detect
demonstr
accuraci
pct
discrimin
patient
microbiolog
confirm
bacteri
viral
cap
patient
without
pathogen
detect
unknown
etiolog
fungal
mycobacteri
pathogen
exclud
analysi
focu
could
confid
categor
bacteri
viral
group
second
compar
typic
bacteria
group
combin
group
virus
atyp
bacteria
routin
coverag
atyp
bacteria
empir
antibiot
regimen
cap
controversi
evalu
pct
accuraci
specif
typic
bacteri
cap
antibiot
univers
recommend
third
compar
patient
bacteri
pathogen
detect
includ
typic
atyp
bacteria
patient
bacteria
detect
includ
patient
viral
fungal
mycobacteri
detect
pathogen
detect
analysi
pct
accuraci
bacteri
cap
assum
patient
unknown
etiolog
undiagnos
bacteri
diseas
dichotom
analys
construct
nonparametr
receiv
oper
characterist
roc
curv
evalu
diagnost
accuraci
pct
discrimin
bacteri
cap
compar
group
area
curv
auc
calcul
sensit
specif
posit
neg
predict
valu
calcul
use
pct
cutpoint
ngml
ngml
ngml
also
assess
associ
pct
concentr
continu
scale
probabl
bacteri
cap
pct
valu
highli
skew
thu
model
pct
valu
restrict
cubic
spline
function
knot
locat
percentil
use
predict
probabl
logist
regress
model
splinetransform
pct
concentr
independ
variabl
cap
pathogen
group
bacteri
vs
compar
depend
variabl
estim
probabl
bacteri
cap
accord
pct
concentr
statist
analys
perform
stata
softwar
version
statacorp
colleg
station
texa
studi
period
patient
radiograph
pneumonia
specimen
avail
bacteri
viral
test
enrol
patient
pct
measur
includ
current
analysi
figur
median
age
year
interquartil
rang
iqr
common
comorbid
asthma
chronic
obstruct
pulmonari
diseas
admit
icu
mechan
ventil
die
hospit
supplementari
tabl
pathogen
detect
patient
classifi
viral
group
atyp
bacteri
group
typic
bacteri
group
mycobacterialfung
group
common
pathogen
viral
atyp
bacteri
typic
bacteri
group
rhinoviru
n
pneumonia
n
pneumonia
n
respect
supplementari
tabl
eight
patient
atyp
group
concomit
viral
detect
patient
typic
bacteri
group
concomit
viral
n
atyp
n
detect
clinic
characterist
pathogen
detect
similar
patient
includ
current
analysi
patient
epic
studi
exclud
serum
pct
measur
avail
supplementari
tabl
median
pct
lower
viral
group
ngml
iqr
ngml
compar
atyp
bacteri
group
ngml
iqr
ngml
p
typic
bacteri
group
ngml
iqr
ngml
p
figur
typic
bacteria
preval
higher
pct
concentr
among
patient
pct
ngml
among
patient
pct
ngml
tabl
typic
bacteria
preval
higher
pct
strata
among
patient
icu
gener
medic
floor
supplementari
tabl
among
patient
typic
bacteria
detect
pct
ngml
pct
ngml
median
pct
higher
patient
typic
bacteria
ngml
iqr
ngml
compar
typic
bacteri
viral
codetect
ngml
iqr
ngml
p
supplementari
figur
median
pct
also
higher
patient
typic
bacteria
detect
blood
cultur
ngml
iqr
ngml
respiratori
sampl
ngml
iqr
ngml
p
urinari
antigen
test
ngml
iqr
ngml
p
supplementari
figur
use
pct
discrimin
bacteri
pathogen
n
viral
pathogen
n
result
area
roc
curv
ci
figur
use
pct
threshold
ngml
identifi
bacteri
pathogen
result
sensit
ci
specif
tabl
consid
pct
continu
scale
use
logist
regress
model
probabl
detect
bacteri
pathogen
increas
substanti
increas
pct
nonlinear
fashion
figur
undetect
pct
ngml
associ
ci
probabl
bacteri
detect
pct
ngml
associ
ci
probabl
bacteri
detect
use
pct
discrimin
typic
bacteri
pathogen
n
combin
group
viral
atyp
pathogen
n
result
area
roc
curv
ci
figur
pct
threshold
ngml
identifi
typic
bacteri
pathogen
sensit
ci
specif
ci
tabl
patient
undetect
pct
ngml
probabl
typic
bacteri
pathogen
detect
ci
patient
pct
ngml
probabl
typic
bacteri
pathogen
increas
ci
figur
interestingli
pct
higher
legionella
detect
median
ngml
atyp
bacteria
includ
mycoplasma
median
ngml
chlamydophila
median
ngml
supplementari
tabl
within
full
popul
includ
patient
unknown
etiolog
use
pct
discrimin
patient
bacteri
pathogen
n
without
detect
bacteri
pathogen
n
result
area
roc
curv
ci
figur
pct
threshold
ngml
result
sensit
ci
specif
ci
identif
patient
bacteri
pathogen
tabl
multicent
studi
adult
hospit
cap
includ
viral
bacteri
pathogen
detect
higher
level
serum
pct
hospit
admiss
strongli
associ
increas
probabl
bacteri
pathogen
detect
patient
pct
ngml
time
like
bacteri
pathogen
detect
undetect
pct
ngml
pct
threshold
allow
perfect
discrimin
viral
bacteri
detect
demonstr
patient
typic
bacteri
pathogen
pct
ngml
pct
ngml
howev
data
suggest
serum
pct
concentr
avail
clinician
within
minut
simpl
blood
draw
could
use
adjunct
etiolog
assess
patient
hospit
cap
sever
recent
trial
suggest
institut
antibiot
prescrib
guidelin
base
pct
level
safe
curtail
use
antibiot
respiratori
infect
inpati
outpati
set
guidelin
use
trial
discourag
antibiot
patient
pct
ngml
strongli
discourag
antibiot
pct
ngml
studi
knowledg
largest
date
evalu
associ
pct
pneumonia
etiolog
provid
import
data
complement
trial
among
patient
pct
ngml
studi
typic
bacteri
pathogen
detect
atyp
bacteri
pathogen
detect
among
patient
pct
ngml
typic
bacteria
atyp
bacteria
detect
result
demonstr
lower
frequenc
bacteri
pathogen
patient
popul
pct
ngml
ngml
threshold
individu
patient
bacteri
pathogen
present
hospit
low
pct
level
highlight
clinician
reli
pct
alon
guid
antibiot
treatment
decis
interestingli
pct
valu
patient
atyp
bacteria
similar
virus
typic
bacteria
particularli
true
mycoplasma
chlamydophila
legionella
routin
coverag
atyp
bacteria
empir
antibiot
cap
regimen
controversi
mycoplasma
chlamydophila
infect
often
selflimit
low
mortal
risk
clinic
trial
data
fail
consist
demonstr
improv
patient
outcom
atyp
coverag
ad
monotherapi
propon
empir
atyp
coverag
note
antibiot
improv
outcom
patient
legionella
pneumonia
may
shorten
durat
symptom
mycoplasma
pneumonia
controversi
analyz
data
atyp
bacteria
group
typic
bacteria
atyp
bacteria
group
virus
result
suggest
pct
better
marker
typic
bacteria
combin
group
typic
atyp
bacteria
although
small
sampl
size
patient
legionella
pneumonia
n
prevent
robust
evalu
pct
specif
legionella
studi
rel
high
pct
patient
suggest
pct
respons
legionella
pneumonia
may
similar
typic
bacteri
pneumonia
mycoplasma
chlamydophila
pneumonia
confirm
futur
studi
elev
pct
indic
increas
probabl
pathogen
necessit
prompt
antibiot
typic
bacteria
legionella
low
pct
indic
increas
probabl
pathogen
requir
prompt
antibiot
virus
mycoplasma
chlamydophila
could
use
paradigm
strength
studi
systemat
protocoldriven
pathogen
test
includ
tradit
culturebas
serolog
test
well
pcrbase
techniqu
despit
thorough
test
patient
pathogen
detect
high
proport
patient
unknown
etiolog
similar
contemporari
cap
studi
present
challeng
evalu
accuraci
pct
identifi
bacteri
pneumonia
ideal
pct
would
evalu
popul
cap
patient
identifi
pathogen
enabl
complet
precis
classif
bacteri
nonbacteri
diseas
unfortun
identif
pathogen
patient
possibl
current
avail
test
therefor
approach
includ
calcul
pct
accuraci
within
microbiolog
confirm
popul
n
patient
identifi
bacteri
viral
pathogen
full
popul
n
includ
patient
without
pathogen
detect
popul
limit
microbiolog
confirm
popul
directli
generaliz
clinic
practic
clinician
know
patient
test
posit
pathogen
make
initi
decis
antibiot
meanwhil
full
popul
like
includ
patient
misclassifi
nonbacteri
group
due
failur
pathogen
test
detect
relev
bacteria
togeth
complementari
analys
provid
estim
rang
accuraci
pct
identifi
bacteri
cap
import
reassess
pct
accuraci
pathogen
test
cap
improv
patient
classifi
bacteri
viral
group
prior
work
kruger
et
al
studi
pct
popul
inpati
outpati
cap
includ
patient
identifi
pathogen
compar
kruger
et
al
found
similar
pattern
pct
across
etiolog
group
identifi
higher
preval
virus
found
higher
pct
bacteri
group
possibl
due
pcr
test
virus
inclus
sever
ill
patient
popul
limit
hospit
patient
studi
studi
limit
first
patient
enrol
epic
studi
includ
analysi
serum
specimen
pct
measur
avail
potenti
introduc
select
bia
measur
clinic
characterist
detect
pathogen
similar
includ
exclud
patient
second
protocol
recommend
serial
pct
measur
guid
antibiot
prescrib
measur
pct
time
hospit
admiss
third
invas
diagnost
test
eg
thoracentesi
bronchoscopi
util
deem
medic
necessari
treat
physician
studydict
invas
test
may
result
patient
identifi
pathogen
fourth
detect
pathogen
may
repres
caus
agent
pneumonia
exampl
virus
detect
npop
swab
may
repres
infect
limit
upper
airway
asymptomat
shed
fifth
sampl
patient
pathogen
time
hospit
admiss
delay
bacteri
pneumonia
develop
initi
viral
infect
would
detect
sampl
method
final
enrol
patient
hospit
unabl
comment
pct
outpati
pneumonia
conclus
although
pct
threshold
perfectli
discrimin
bacteria
virus
higher
serum
pct
strongli
correl
increas
probabl
bacteri
pathogen
data
suggest
pct
could
assist
clinician
evalu
potenti
pathogen
highlight
base
antibiot
prescrib
decis
exclus
pct
would
result
proport
patient
bacteri
pneumonia
receiv
antibiot
